68.01
+0.30
+(0.44%)
As of 2:49:30 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
4,372,000
4,372,000
4,504,000
4,584,000
4,526,000
Cost of Revenue
1,511,000
1,511,000
1,760,000
1,612,000
1,372,000
Gross Profit
2,861,000
2,861,000
2,744,000
2,972,000
3,154,000
Operating Expense
2,261,000
2,261,000
2,966,000
2,618,000
3,277,000
Operating Income
600,000
600,000
-222,000
354,000
-123,000
Net Non Operating Interest Income Expense
-54,000
-54,000
-19,000
-15,000
-61,000
Other Income Expense
-1,725,000
-1,725,000
-876,000
-4,675,000
1,068,000
Pretax Income
-1,179,000
-1,179,000
-1,117,000
-4,336,000
884,000
Tax Provision
44,000
44,000
44,000
68,000
122,000
Net Income Common Stockholders
-1,223,000
-1,223,000
-1,161,000
-4,404,000
762,000
Diluted NI Available to Com Stockholders
-1,223,000
-1,223,000
-1,161,000
-4,404,000
762,000
Basic EPS
-9.97
-7.69
-7.34
-28.00
5.07
Diluted EPS
-9.97
-7.69
-7.34
-28.00
5.04
Basic Average Shares
158,750
159,000
158,000
157,000
150,000
Diluted Average Shares
158,750
159,000
158,000
157,000
151,000
Total Operating Income as Reported
-833,000
-833,000
-1,069,000
-4,179,000
-123,000
Total Expenses
3,772,000
3,772,000
4,726,000
4,230,000
4,649,000
Net Income from Continuing & Discontinued Operation
-1,223,000
-1,223,000
-1,161,000
-4,404,000
762,000
Normalized Income
-90,930
-90,930
-491,870
-822,930
-76,726
Interest Income
46,000
46,000
58,000
11,000
--
Interest Expense
100,000
100,000
77,000
26,000
61,000
Net Interest Income
-54,000
-54,000
-19,000
-15,000
-61,000
EBIT
-1,079,000
-1,079,000
-1,040,000
-4,310,000
945,000
EBITDA
-725,000
-725,000
-608,000
-3,916,000
1,196,000
Reconciled Cost of Revenue
1,511,000
1,511,000
1,760,000
1,612,000
1,372,000
Reconciled Depreciation
354,000
354,000
432,000
394,000
251,000
Net Income from Continuing Operation Net Minority Interest
-1,223,000
-1,223,000
-1,161,000
-4,404,000
762,000
Total Unusual Items Excluding Goodwill
-1,433,000
-1,433,000
-847,000
-4,533,000
973,000
Total Unusual Items
-1,433,000
-1,433,000
-847,000
-4,533,000
973,000
Normalized EBITDA
708,000
708,000
239,000
617,000
223,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-300,930
-300,930
-177,870
-951,930
134,274
12/31/2021 - 8/2/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IJF.MU Icon PLC
140.10
+10.10%
MTO.MU Mettler-Toledo International Inc
956.40
+9.70%
SLDX Stella Diagnostics, Inc.
0.0490
0.00%
IDTA IDenta Corp.
0.5500
0.00%
TMOF.VI Thermo Fisher Scientific Inc.
402.25
+6.88%
GDR.L genedrive plc
1.5600
+3.65%
LO3A.BE Lonza Group Ltd
56.50
+4.63%
IMMNOV.ST Immunovia AB (publ)
0.2640
+2.13%
DAP.F Danaher Corporation
174.92
+4.44%
LZAGY Lonza Group AG
62.79
-2.88%